药物诱导性膜性肾病:拼凑线索以理解疾病机制
本文综述药物诱导性膜性肾病的研究进展,涉及硫辛酸补充剂、美白霜中的汞和非甾体抗炎药等致病药物,及其与新发现的靶抗原神经表皮生长因子样1和原蛋白转化酶枯草杆菌蛋白酶/kexin 6型的关联,并基于历史研究提出药物促进免疫失调的新假说。
要点
- 药物诱导性膜性肾病蛋白尿从低级别到肾病范围,停药后数月内多可缓解。
- 组织学以IgG1亚类为主的上皮下沉积为特征,有时呈节段性分布。
- 相关抗原为神经表皮生长因子样1和原蛋白转化酶枯草杆菌蛋白酶/kexin 6型。
核心结论
- 药物诱导性膜性肾病与特定药物及新发现的靶抗原相关,其机制可能涉及含巯基药物的免疫失调作用。
研究设计与样本
- 本文为综述,基于对金盐、青霉胺和汞相关膜性肾病的历史研究进行探讨。
主要发现
- 药物诱导性膜性肾病蛋白尿范围从低级别到肾病范围,停药后数月内一般缓解。
- 组织学特征为IgG1亚类为主的上皮下沉积,有时呈独特节段性分布。
- 相关抗原为神经表皮生长因子样1和原蛋白转化酶枯草杆菌蛋白酶/kexin 6型。
- 多种致病药物含一个或多个巯基,可能具有机制相关性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
There is a resurgence of interest in drug-induced membranous nephropathy because of the widespread availability of recently discovered culprit medications, such as lipoic acid supplements, mercury in skin-lightening creams, and nonsteroidal anti-inflammatory drugs, and the relationship between these drugs and newly described target antigens. The clinical syndromes associated with drug-induced membranous nephropathy are similar in that proteinuria ranges from low grade to nephrotic range and generally remits within months of drug cessation. Histology is notable for subepithelial deposits that are IgG1 subclass predominant, sometimes with a unique segmental distribution. The two antigens associated with drug-induced membranous nephropathy are neural epidermal growth factor-like 1 and proprotein convertase subtilisin/kexin type 6. Notably, several of the culprit drugs contain one or more sulfhydryl groups that may have potential mechanistic relevance. In this review, we explore past research investigations into mechanisms of membranous nephropathy associated with gold salts, penicillamine, and mercury and use these historical studies as the basis for formulating new hypotheses on how drugs might promote immune dysregulation and, ultimately, membranous nephropathy.
引用
- Avasare RS, Andeen NK, Al-Rabadi LF, et al. Drug-Induced Membranous Nephropathy: Piecing Together Clues to Understand Disease Mechanisms. J Am Soc Nephrol. 2025. PMID: 40198910. doi:10.1681/ASN.0000000719
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。